Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Lymphotoxins: New Targets for Hepatocellular Carcinoma
Cancer Cell, 10/12/09
Villanueva A et al. – In this issue of Cancer Cell, Haybaeck et al. unravel the role of lymphotoxin pathway in the development of hepatocellular carcinoma (HCC). Aberrant activation of this cascade in mice livers recapitulates the stages of fibrosis and inflammation that precedes human liver cancer, providing a novel family of potential therapeutic targets.
Related Articles
Soluble lymphotoxin is an important effector molecule in GVHD and GVL
Blood, 10/02/09
Relevance Score: 84%
Id2-, ROR{gamma}t-, and LT{beta}R-independent initiation of lymphoid organogenesis in ocular immunity
Journal of Experimental Medicine, 11/03/09
Relevance Score: 80%
LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytes
International Journal of Obesity, 10/12/09
Relevance Score: 80%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Association between global DNA hypomethylation in leukocytes and risk of breast cancer
Carcinogenesis, 11/30/09
The Rac1/MKK7/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras
Carcinogenesis, 11/30/09
The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment
Carcinogenesis, 11/30/09
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
The Lancet Oncology - Online First, 11/30/09
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
The Lancet Oncology - Online First, 11/30/09
Hepatoblastoma metastatic to the right atrium responding to chemotherapy alone
Pediatric Hematology and Oncology, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


